Logo

Cornell Research Foundation

Cornell Files Objection to Forced Arbitration With Life Tech

The university is arguing that the judge had no basis to compel arbitration of what Cornell is claiming is a fraudulent settlement.

Cornell Seeks to Rescind Settlement of Patent Dispute Against Illumina

The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.

IP Roundup: Corning, NVS Technologies, Cornell Research Foundation, Luminex
Premium

Title: Single-cell label-free assay. Patent Number: 8,703,428 Filed: May 28, 2008 Lead Inventor: Ye Fang, Corning

IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Jun 14, 2011
Premium

Cornell Research Foundation, Agilent Technologies, and the Finnish Defence Forces are awarded US patents.

IP Roundup: May 17, 2011
Premium

Erie Scientific, Eppendorf, Cornell Research Foundation, Affymetrix, Centre National de la Recherche, Rosetta Genomics

Mar 29, 2011

IP Roundup: Mar 29, 2011
Premium

Feb 22, 2011

IP Roundup: Feb 22, 2011
Premium

Aug 24, 2010

IP Roundup: Aug 25, 2010
Premium

Jul 7, 2009

IP Roundup: Jul 7, 2009
Premium

Mar 3, 2009

Sequencing Patents of Note
Premium

Breaking News
The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.